COVID vaccines are back under review and the move is raising concern among some health experts. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices is slated ...

The approval was based on a cohort of treatment-naïve patients in the Beamion LUNG-1 trial who had unresectable or metastatic, non-squamous NSCLC with HER2 tyrosine kinase domain mutations.

Results from ADAPT OCULUS are expected to support a sBLA submission to the FDA to secure a label expansion for oMG.

The Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for olezarsen in the treatment of severe hypertriglyceridemia.

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online February 18 in eClinicalMedicine.